Trupanion, Inc. (NASDAQ:TRUP) Shares Sold by Connors Investor Services Inc.

Connors Investor Services Inc. lessened its position in shares of Trupanion, Inc. (NASDAQ:TRUP) by 0.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 76,415 shares of the financial services provider’s stock after selling 544 shares during the quarter. Connors Investor Services Inc. owned about 0.18% of Trupanion worth $3,683,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Baillie Gifford & Co. grew its holdings in shares of Trupanion by 26.6% during the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after buying an additional 147,341 shares during the last quarter. First Trust Advisors LP acquired a new stake in shares of Trupanion during the 4th quarter valued at approximately $7,083,000. Dimensional Fund Advisors LP increased its stake in Trupanion by 112.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider’s stock valued at $13,204,000 after purchasing an additional 144,828 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Trupanion by 458.3% during the fourth quarter. JPMorgan Chase & Co. now owns 158,099 shares of the financial services provider’s stock worth $7,620,000 after purchasing an additional 129,782 shares during the last quarter. Finally, Invesco Ltd. boosted its position in Trupanion by 122.0% during the fourth quarter. Invesco Ltd. now owns 226,652 shares of the financial services provider’s stock worth $10,925,000 after purchasing an additional 124,549 shares in the last quarter.

Trupanion Stock Performance

Trupanion stock opened at $37.82 on Wednesday. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The company has a market cap of $1.61 billion, a price-to-earnings ratio of -164.43, a price-to-earnings-growth ratio of 6.02 and a beta of 1.66. The stock’s 50-day moving average is $35.24 and its 200-day moving average is $45.13.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The company had revenue of $337.31 million for the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. Equities analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insider Buying and Selling

In other Trupanion news, CEO Margaret Tooth sold 2,294 shares of the company’s stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total value of $72,008.66. Following the transaction, the chief executive officer now directly owns 118,784 shares of the company’s stock, valued at $3,728,629.76. This represents a 1.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Fawwad Qureshi sold 1,373 shares of Trupanion stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total transaction of $46,984.06. Following the completion of the sale, the chief financial officer now owns 2,416 shares of the company’s stock, valued at approximately $82,675.52. This trade represents a 36.24 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,792 shares of company stock valued at $1,122,802 in the last quarter. Company insiders own 5.50% of the company’s stock.

Wall Street Analyst Weigh In

TRUP has been the topic of a number of research reports. Stifel Nicolaus lowered their price objective on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Piper Sandler lowered their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $46.60.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.